Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01959490
Title Trastuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Case Comprehensive Cancer Center
Indications

breast adenocarcinoma

Therapies

Bevacizumab + Cyclophosphamide + Doxorubicin + Paclitaxel

Carboplatin + Docetaxel + Trastuzumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.